NASDAQ: PBM
Psyence Biomedical Ltd Stock Ownership - Who owns Psyence Biomedical?

Insider buying vs selling

Have Psyence Biomedical Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PBM insiders and whales buy or sell their stock.

PBM Shareholders

What type of owners hold Psyence Biomedical Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Marc Gregory Balkin325.08%7,455,000$49.39MInsider
Newcourt Spac Sponsor LLC40.12%920,000$6.10MInsider
Polar Asset Management Partners Inc23.11%530,000$3.51MInsider
Goldman Sachs Group Inc0.16%3,749$24.84kInsider
Parall0.01%151$1.00kInstitution
Parallel Advisors LLC0.01%151$1.00kInstitution
Advis50.01%122$808.25Institution
Advisorshares Investments LLC0.01%122$808.25Institution
Morsta0.00%38$251.75Institution
Morgan Stanley0.00%37$245.13Institution

1 of 2

PBM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PBM0.00%100.00%
DYAI0.01%99.99%Net SellingNet Selling
PASG0.00%100.00%Net BuyingNet Buying
LSTA0.00%100.00%Net Selling
MBRX0.00%32.51%Net SellingNet Selling

Psyence Biomedical Stock Ownership FAQ

Who owns Psyence Biomedical?

Psyence Biomedical (NASDAQ: PBM) is owned by 0.02% institutional shareholders, 388.47% Psyence Biomedical insiders, and 0.00% retail investors. Marc Gregory Balkin is the largest individual Psyence Biomedical shareholder, owning 7.46M shares representing 325.08% of the company. Marc Gregory Balkin's Psyence Biomedical shares are currently valued at $49.39M.

If you're new to stock investing, here's how to buy Psyence Biomedical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.